Recomienda este artículo a tus amigos:
Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations - Chapman & Hall / CRC Biostatistics Series
Precio
Mex$ 4.566
sin IVA
Pedido desde almacén remoto
Entrega prevista 31 de ago. - 16 de sep.
Nuestros clientes opinan:
Añadir a tu lista de deseos de iMusic
Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations - Chapman & Hall / CRC Biostatistics Series
Development of Gene Therapies: Strategic, Scientific, and Regulatory, and Access Considerations attempts to summarize the current state-of-the-art strategic, scientific, statistical, and regulatory aspects of GTx development.
488 pages, 1 Tables, color; 19 Tables, black and white; 36 Line drawings, color; 1 Line drawings, bl
| Medios de comunicación | Libros Hardcover Book (Libro con lomo y cubierta duros) |
| Publicado | 23 de mayo de 2024 |
| ISBN13 | 9781032136554 |
| Editores | Taylor & Francis Ltd |
| Páginas | 458 |
| Dimensiones | 150 × 220 × 20 mm · 1,07 kg |
| Lengua | Inglés |
| Editor | McIntosh, Avery (Apellis Pharmaceuticals|Novartis, USA) |
| Editor | Sverdlov, Oleksandr (Apellis Pharmaceuticals|Novartis, USA) |
